| Financial Year |
March 31 2023 |
| Monetary Funds |
2,128,419,649.44 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
300,034,405.43 |
| Accounts Receivable |
3,475,106,785.53 |
| Advances to Suppliers |
191,471,910.90 |
| Other Receivables |
347,572,862.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,437,965,456.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
428,034,258.16 |
| Total Current Assets |
18,004,056,694.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
152,131,484.62 |
| Investment Properties |
948,636,099.80 |
| Fixed Assetes |
808,060,936.93 |
| Under-construction Projects |
52,737,441.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
225,495,275.30 |
| R&D expenses |
-- |
| Goodwill |
232,544,040.32 |
| Long-Term Deferred and Prepaid Expenses |
59,302,747.55 |
| Deferred Income Tax Assets |
507,992,853.31 |
| Other Non-Current Assets |
863,812,999.22 |
| Sub-Total of Non-Current Assets |
3,998,150,295.80 |
| Total Assets |
22,002,206,990.29 |
| Short-Term Loans |
1,924,066,566.25 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,455,927,222.43 |
| Accounts Payable |
7,157,257,062.58 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
66,096,664.27 |
| Taxes Payable |
115,351,617.82 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
460,830,218.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
136,511,061.00 |
| Other Current Liabilities |
796,322,434.78 |
| Sub-Total of Current Liabilities |
13,794,248,768.46 |
| Long-term Loans |
9,800,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
35,361,471.03 |
| Deferred Income Tax Liabilities |
100,813,703.69 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
190,805,999.13 |
| Total Liabilities |
13,985,054,767.59 |
| Paid-In Capital(Or Share Stock) |
1,339,996,498.00 |
| Capital Surplus |
1,891,575,108.33 |
| Surplus Reserve |
396,652,818.92 |
| LESS:Treasury Stock |
61,419,600.00 |
| Undistributed Profits |
4,126,227,399.40 |
| Minority Stockholder's Interest |
298,127,005.15 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,719,025,217.55 |
| Owner's Equity（Stockholder's Equity） |
8,017,152,222.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
22,002,206,990.29 |
